Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Protokinetix, Inc. PKTX

ProtoKinetix Inc is a research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins). The AFGP is a compound produced by fish, insects, reptiles, bacteria, and plants that enable survival in freezing temperatures. The company also develops AFGP applications which include regenerative medicine issues including harvesting, processing, storage and transplanting cells, tissues and organs and treatments for chronic inflammatory conditions and diseases caused by stress factors, including UV radiation, oxidation, and cryopreservation and hydrogen peroxide.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (OTCQB:PKTX)

Fundamentals Snapshot (OTCQB:PKTX)

Opinion & Analysis (OTCQB:PKTX)

No current opinion is available.

Bullboard Posts (OTCQB:PKTX)

zero activity

Is this company hand cream or what?
lashing - May 4, 2022

ProtoKinetix help me retire early baby!

To the moon! Baby! http://investorshub.advfn.com/ProtoKinetix-Inc-PKTX-2457/
SlimCarlos - January 23, 2017

target price

On their website they post a $1.32 target price. Grosvenor Financial Partners LLC Initial Report 9/26/07. Here, I'll paste it for you...
lindbeck - October 15, 2007

Peter Hodson...

& this man, on BNN, says that cdn. biotech is performing poorly. He would not buy unless Phase 3 results came out. FDA approval...
lindbeck - October 15, 2007

RE: Update,

I know very little about the company; got in on a "tip". I did call them a few weeks ago to gauge the market and did not get a...
Symmetrix - October 12, 2007

Update,

Does anyone have anything to say, good or bad, about this company? I'm really dying to know why the huge drop in s/p.
lindbeck - October 11, 2007